Terms: = Ovarian cancer AND Ki-67 AND Staging
16 results:
1. Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: A historical cohort study.
Kong S; Sun J; Sui X; Zhang S; Qi Y; Ma Y; Li S
Acta Obstet Gynecol Scand; 2023 Jul; 102(7):935-941. PubMed ID: 37059424
[TBL] [Abstract] [Full Text] [Related]
2. Primary squamous cell carcinoma of the ovary accompanied by transition of a mucinous borderline ovarian tumor.
Bak S; Hong JY; Lee JW; Im S; Park DC
J Int Med Res; 2023 Feb; 51(2):3000605221098177. PubMed ID: 36734245
[TBL] [Abstract] [Full Text] [Related]
3. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
4. Apparent Diffusion Coefficient Histogram Analysis for Assessing Tumor staging and Detection of Lymph Node Metastasis in Epithelial ovarian cancer: Correlation with p53 and ki-67 Expression.
Wang F; Wang Y; Zhou Y; Liu C; Liang D; Xie L; Yao Z; Liu J
Mol Imaging Biol; 2019 Aug; 21(4):731-739. PubMed ID: 30456593
[TBL] [Abstract] [Full Text] [Related]
5. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to ki-67: A new prognostic biomarker.
Wang J; Liu Q; Zhou X; He Y; Guo Q; Shi Q; Eriksson S; Zhou J; He E; Skog S
Tumour Biol; 2017 Jun; 39(6):1010428317706479. PubMed ID: 28651488
[TBL] [Abstract] [Full Text] [Related]
6. Is Estradiol Monitoring Necessary in Women Receiving ovarian Suppression for Breast cancer?
Papakonstantinou A; Foukakis T; Rodriguez-Wallberg KA; Bergh J
J Clin Oncol; 2016 May; 34(14):1573-9. PubMed ID: 26951320
[TBL] [Abstract] [Full Text] [Related]
7. Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.
Zhao Y; Chen S; Gou WF; Xiao LJ; Takano Y; Zheng HC
Tumour Biol; 2014 Mar; 35(3):1955-64. PubMed ID: 24132590
[TBL] [Abstract] [Full Text] [Related]
8. [The value of ki-67 antigen expression in tissue microarray method in prediction prognosis of patients with endometrioid endometrial cancer].
Gottwald L; Kubiak R; Sek P; Piekarski J; Szwalski J; Pasz-Walczak G; Spych M; Suzin J; TyliĆskis W; Jeziorski A
Ginekol Pol; 2013 Jun; 84(6):444-9. PubMed ID: 24032262
[TBL] [Abstract] [Full Text] [Related]
9. The role of EMMPRIN expression in ovarian epithelial carcinomas.
Zhao Y; Chen S; Gou WF; Niu ZF; Zhao S; Xiao LJ; Takano Y; Zheng HC
Cell Cycle; 2013 Sep; 12(17):2899-913. PubMed ID: 23966157
[TBL] [Abstract] [Full Text] [Related]
10. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
[TBL] [Abstract] [Full Text] [Related]
11. Granulosa cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 21 cases.
Kondi-Pafiti A; Grapsa D; Kairi-Vassilatou E; Carvounis E; Hasiakos D; Kontogianni K; Fotiou S
Eur J Gynaecol Oncol; 2010; 31(1):94-8. PubMed ID: 20349790
[TBL] [Abstract] [Full Text] [Related]
12. Primary bilateral ovarian and uterine Burkitt's lymphoma following chemotherapy for breast cancer.
Hatami M; Whitney K; Goldberg GL
Arch Gynecol Obstet; 2010 Apr; 281(4):697-702. PubMed ID: 19756677
[TBL] [Abstract] [Full Text] [Related]
13. Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome.
Abd-Elaziz M; Akahira J; Moriya T; Suzuki T; Yaegashi N; Sasano H
Cancer Sci; 2003 Nov; 94(11):980-5. PubMed ID: 14611675
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer.
Fanning J; Brown S; Phibbs G; Kramer T; Zaher A
Int J Gynecol Cancer; 2002; 12(3):286-9. PubMed ID: 12060450
[TBL] [Abstract] [Full Text] [Related]
15. Expression and prognostic significance of proliferating cell nuclear antigen and ki-67 in malignant ovarian germ cell tumors.
Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299
[TBL] [Abstract] [Full Text] [Related]
16. Micrometastatic bone marrow involvement: detection and prognostic significance.
Braun S; Pantel K
Med Oncol; 1999 Sep; 16(3):154-65. PubMed ID: 10523795
[TBL] [Abstract] [Full Text] [Related]